Mission statement · Company scope
“Our mission is to transform cancer therapy by reducing normal tissue toxicity induced by radiotherapy and increasing the anti-cancer efficacy of radiotherapy with the use of our dismutase mimetics.”
In use2023 – now1 sighting
First seenMar 2023Added
Last seenMar 2023Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Problem–solution (primary) · Impact · Innovation
- Leads with
- Problem
- Best for
- Climate & health · Service business
- Formula
- [Problem] shouldn’t [cost]. We [how].
- Tone
- Plain
- Length
- 29 words · reading grade 20.5
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_0eed12eee21d6513
- Classification confidence
- 0.59
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2023-03-08 · sec_sentence · 10-K · accession 0000950170-23-006588
View filing ↗0 to compareCompare